Atlas Trials

A Long-term Follow-up Study in Participants Who Received CS-101

Clinical trial NCT06685536 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06685536
Sponsor
CorrectSequence Therapeutics Co., Ltd
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Beta-Thalassemia
Start date
2025-01-18
Primary completion
2039-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.